AZN - AstraZeneca PNH drug gets first regulatory approval in Japan
2024-01-19 16:36:53 ET
More on AstraZeneca
- Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win
- AstraZeneca: A $1.1B Shot In The Arm From Icosavax Acquisition
- AstraZeneca Is Feeling The Weight Of The Market In 2023
- Icosavax ticks lower as HSR filing for AstraZeneca deal withdrawn, refiled
- Eli Lilly’s Jaypirca to lead BTK inhibitor market for leukemia
For further details see:
AstraZeneca PNH drug gets first regulatory approval in Japan